TWD 16.9
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 72.02 Million TWD | -22.78% |
2022 | 93.26 Million TWD | 8981.4% |
2021 | 1.02 Million TWD | -99.21% |
2020 | 130.47 Million TWD | -9.58% |
2019 | 144.29 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 61.91 Million TWD | -12.88% |
2024 Q2 | 61.91 Million TWD | 0.0% |
2023 Q3 | 71.07 Million TWD | -13.58% |
2023 FY | 72.02 Million TWD | -22.78% |
2023 Q1 | 80.22 Million TWD | -13.98% |
2023 Q2 | 82.23 Million TWD | 2.51% |
2023 Q4 | 72.02 Million TWD | 1.34% |
2022 Q4 | 93.26 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | 5.417% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 78.204% |
TTY Biopharm Company Limited | 403.04 Million TWD | 82.13% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 95.062% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 96.731% |
Center Laboratories, Inc. | 4.42 Billion TWD | 98.374% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -19004.509% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 77.752% |
InnoPharmax Inc. | 5.38 Million TWD | -1237.245% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | 28.57% |
Excelsior Biopharma Inc. | 300.25 Million TWD | 76.012% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 77.189% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -449.173% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -838.913% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 85.586% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -52091.304% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -28.484% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -72.852% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -9.701% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |